Debt Instrument [Axis]
Baker Bros Notes [Member]
Related Party [Member]
Adjuvant Notes [Member]
Class of Stock [Axis]
Series E-1 Convertible and Redeemable Preferred Stock [Member]
Series F-1 Convertible and Redeemable Preferred Stock [Member]
Series G-1 Convertible and Redeemable Preferred Stock [Member]
Equity Components [Axis]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Concentration Risk Benchmark [Axis]
Revenue Benchmark [Member]
Customer [Axis]
Three Largest Customers Combined [Member]
Concentration Risk Type [Axis]
Customer Concentration Risk [Member]
Accounts Receivable [Member]
Statistical Measurement [Axis]
Maximum [Member]
Antidilutive Securities [Axis]
Share-Based Payment Arrangement, Option [Member]
Warrant [Member]
Series E-1 Shares [Member]
Series F-1 Shares [Member]
Series G-1 Shares [Member]
Rights [Member]
Convertible Debt Securities [Member]
Convertible Debt [Member]
Minimum [Member]
Statement Of Financial Positions Location Balance [Axis]
Trade Accounts Receivable [Member]
Others Current Liabilities [Member]
Long-Term Debt, Type [Axis]
Convertible Notes Payable [Member]
Baker Second Closing Notes [Member]
Debt Instrument, Redemption, Period [Axis]
Debt Instrument, Redemption, Period Two [Member]
Debt Instrument, Redemption, Period One [Member]
Class of Warrant or Right [Axis]
June 2022 Baker Warrants [Member]
Second Baker Amendment [Member]
Baker Warrants [Member]
Third Baker Amendment [Member]
Secured Creditor Forbearance Agreement [Member]
Short-term Convertible Notes [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Common Stock Agreements [Member]
Short-Term Debt, Type [Axis]
Unsecured Debt [Member]
A80 Senior Subordinated Notes Due 2025 Issued December2022 [Member]
Securities Purchase Agreements [Member]
Series F-1 Convertible Preferred Stock [Member]
Security Purchase Agreement [Member]
Senior Subordinated Notes [Member]
Aditxt Note [Member]
Insurance Premium Finance Agreement [Member]
= $5.0 million [Member]
>$5.0 million and = $7.0 million [Member]
Scenario [Axis]
Quarterly Cash Payment [Member]
Greater than $7.0 million [Member]
Quarterly Cash Payment [Member]
On Or Prior To September 8, 2024 [Member]
Baker Notes [Member]
September 9, 2024 - September 8, 2025 [Member]
September 9, 2025 - September 8, 2026 [Member]
September 9, 2026 - September 8, 2027 [Member]
September 9, 2027 - September 8, 2028 [Member]
December 2022 Notes [Member]
February 2023 Notes [Member]
March 2023 Notes [Member]
March Two 2023 Notes [Member]
April 2023 Notes [Member]
July 2023 Notes [Member]
August 2023 Notes [Member]
September 2023 Notes [Member]
Aditxt April Notes [Member]
Aditxt June Notes [Member]
Counterparty Name [Axis]
Placement Agent [Member]
December 2022 to September 2023 and April to June 2025 [Member]
Common Warrant [Member]
Pre-Funded Warrants [Member]
Long-Lived Asset, Class [Axis]
Equipment [Member]
Computer Equipment and Software [Member]
Construction in Progress [Member]
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 3 [Member]
Aditxt Notes [Member]
Liability Class [Axis]
Long-Term Debt [Member]
Baker Notes Assigned To Future Pak [Member]
Total Offerings and Aditxt Notes [Member]
Derivative Financial Instruments, Liabilities [Member]
Derivative Instrument [Axis]
Measurement Input Type [Axis]
Measurement Input Royalty Rate [Member]
Measurement Input, Discount Rate [Member]
Risk Free Interest Rate [Member]
Valuation Approach and Technique [Axis]
Income Approach [Member]
Discount Rate [Member]
Weighted Average Cost of Capital [Member]
Volatility [Member]
Event Probability [Member]
Exchanged Ssn and Aditxt Notes [Member]
Equity Volatility [Member]
Discount for Lack of Marketability [Member]
Lease Contractual Term [Axis]
Lease Contract Term One [Member]
Vehicles [Member]
Lease Contract Term [Member]
Legal Entity [Axis]
Future Pak LLC [Member]
Rush License Agreement [Member]
Income Statements Location [Axis]
Research and Development Expenses [Member]
Selling and Marketing Expenses [Member]
General and Administrative Expenses [Member]
Baker Bros Purchase Agreement [Member]
Sale of Stock [Axis]
Underwritten Public Offering [Member]
IPO [Member]
June 2022 Baker Warrants [Member]
Warrant One [Member]
Warrant Two [Member]
Warrant Three [Member]
Series E-1 Convertible Preferred Stock [Member]
A&R Merger Agreement [Member]
Series G-1 Convertible Preferred Stock [Member]
Adjuvant and May 2022 Notes [Member]
Common Warrants [Member]
Prefunded Common Warrants [Member]
Plan Name [Axis]
Employee Stock Purchase Plan 2019 [Member]
Amended Inducement Plan [Member]
2025 Plan [Member]
Award Type [Axis]
Statement of Income Locations Balance [Axis]
Research and Development [Member]
Selling and Marketing [Member]
General and Administrative [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Entity Listing, Par Value Per Share
Short-Term Debt [Table]
Short-Term Debt [Line Items]
Assets
Current assets:
Cash and cash equivalents
Restricted cash and cash equivalents
Trade accounts receivable, net
Inventories
Prepaid and other current assets
Total current assets
Property and equipment, net
Operating lease right-of-use assets
Intangible asset, net (Note 7)
Other noncurrent assets
Total assets
Liabilities, convertible and redeemable preferred stock and stockholders’ deficit
Current liabilities:
Accounts payable
Convertible notes (Note 4)
Short-term debt
Accrued expenses
Accrued compensation
Operating lease liabilities – current
Derivative liabilities
Contingent liabilities - current (Note 7)
Other current liabilities
Total current liabilities
Operating lease liabilities – noncurrent
Contingent liabilities - noncurrent (Note 7)
Total liabilities
Commitments and contingencies (Note 7)
Convertible and redeemable preferred stock
Stockholders’ deficit:
Preferred stock, $0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding as of both March 31, 2026 and December 31, 2025
Common Stock, $0.0001 par value; 3,000,000,000 shares authorized; 132,530,081 and 126,685,925 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total stockholders’ deficit
Total liabilities, convertible and redeemable preferred stock and stockholders’ deficit
Statement [Table]
Statement [Line Items]
Convertible preferred stock, par value
Convertible preferred stock, shares authorized
Convertible preferred stock, shares issued
Convertible preferred stock, shares outstanding
Preferred stock, par value
Preferred stock, shares authorized
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Income Statement [Abstract]
Product sales, net
Operating Expenses (Benefits):
Cost of goods sold
Amortization of intangible asset
Research and development, net
Selling and marketing
General and administrative
Total operating expenses
Income (loss) from operations
Other income (expense):
Interest income
Other expense, net
Change in fair value of financial instruments
Total other income (expense), net
Income (loss) before income tax expense
Income tax expense
Net income (loss)
Convertible and redeemable preferred stock deemed dividends
Net income (loss) attributable to common stockholders
Net income (loss) per share attributable to common stockholders:
Basic
Diluted
Weighted-average shares used to compute net income (loss) per share attributable to common shareholders:
Basic
Diluted
Net income (loss)
Other comprehensive income:
Change in fair value of financial instruments attributed to credit risk change (Note 4)
Comprehensive income (loss)
Balance
Balance, shares
Issuance of Common Stock upon noncash conversion of Series G-1 Shares
Issuance of Common Stock upon noncash exercise of purchase rights, shares
Stock-based compensation
Series E-1 Shares dividends
Series E-1 and G-1 Shares dividends, shares
Net income
Balance
Balance, shares
Statement of Cash Flows [Abstract]
Cash flows from operating activities:
Adjustments to reconcile net income (loss) to net cash and cash equivalents and net restricted cash and cash equivalents provided by operating activities:
Change in fair value of financial instruments
Inventory write-down for excess & obsolescence
Loss on contingent liability
Stock-based compensation
Depreciation
Noncash interest expense
Noncash right-of-use asset amortization
Net loss on disposal or impairment of property and equipment
Gain on accounts payable and accrued expenses settlements
Changes in operating assets and liabilities:
Trade accounts receivable
Inventories
Prepaid and other assets
Accounts payable
Accrued expenses and other liabilities
Accrued compensation
Contingent liabilities
Operating lease liabilities
Net cash and cash equivalents and net restricted cash and cash equivalents provided by operating activities
Cash flows from investing activities:
Payments related to intangible asset acquisition
Purchases of property and equipment
Net cash and cash equivalents and net restricted cash and cash equivalents used in investing activities
Cash flows from financing activities:
Payments under short term debt and Notes – carried at fair value
Net cash and cash equivalents and net restricted cash and cash equivalents used in financing activities
Net change in cash and cash equivalents and net restricted cash and cash equivalents
Cash and cash equivalents and restricted cash and cash equivalents beginning of period
Cash, cash equivalents and restricted cash and cash equivalents end of period
Supplemental disclosure of noncash investing and financing activities:
Net decrease in contingent liabilities
Series E-1 Shares and Series G-1 Shares deemed dividends
Issuance of Common Stock upon conversion of Series G-1 Shares
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Equity Awards Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Insider Trading Arrangements [Line Items]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Aggregate Available
Rule 10b5-1 Arrangement Modified
Non-Rule 10b5-1 Arrangement Modified
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Accounting Policies [Abstract]
Description of Business and Basis of Presentation
Summary of Significant Accounting Policies
Revenue from Contract with Customer [Abstract]
Revenue
Debt Disclosure [Abstract]
Debt
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Details
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies
Equity [Abstract]
Convertible and Redeemable Preferred Stock and Stockholders’ Deficit
Share-Based Payment Arrangement [Abstract]
Stock-based Compensation
Subsequent Events [Abstract]
Subsequent Events
Use of Estimates
Segment Reporting
Concentrations of Credit Risk
Significant Accounting Policies
Cash and Cash Equivalents and Restricted Cash and Cash Equivalents
Net Income (Loss) Per Share
Correction of Previously Issued Interim Condensed Consolidated Financial Statements and Prior Period Errors
Recently Adopted Accounting Pronouncements
Schedule of Potentially Dilutive Securities Excluded from Calculation of Diluted Net Income (Loss) Per Share
Schedule of Weighed Average Common Shares Outstanding for Diluted Net Loss Per Share
Schedule of Cash payments Determined based Upon the Quarterly Global Net Revenue
Schedule of Repurchase Price Reduction
Schedule of SSNs and Warrants
Schedule of Inventories
Schedule of Prepaid and Other Current Assets
Schedule of Property and Equipment Net
Schedule of Intangible Assets, Net
Schedule of Accrued Expenses
Schedule of Other Current Liabilities
Schedule of Fair Value of Derivative Liabilities
Schedule of Change in Fair Value of Level 3 Financial Liabilities
Schedule of Lease Cost
Schedule of Lease Term and Discount Rate
Schedule of Operating Lease Maturities
Schedule of Supplement Cash Outflows in Operating Leases
Schedule of Warrants
Summary of Common Stock Reserved for Future Issuance
Schedule of Stock-based Compensation Expense Related to Stock Options
Stockholders equity reverse stock split
Accumulated deficit
Share price
Antidilutive Security, Excluded EPS Calculation [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total
Net income attributable to common stockholders
Noncash interest expense on convertible debt, net of tax
Change in fair value of purchase rights
Net income attributable to common stockholders
Weighted average shares used to compute net income attributable to common stockholders, basic
Pro forma adjustments
Weighted average shares used to compute net income attributable to common stockholders, diluted
Net income per share attributable to common stockholders, diluted
Nature of Operation, Product Information, Concentration of Risk [Table]
Product Information [Line Items]
Number of operating segment
Number of reportablesegment
Concentration risk percentage
Weighted average number of shares outstanding outstanding
Weighted average shares outstanding
Disaggregation of Revenue [Table]
StatementOfFinancialPositionsLocationBalanceAxis [Axis]
[custom:ContractWithCustomerPaymentTerm]
Product revenue variable consideration liability current
Quarterly cash payment
Schedule of Long-Term Debt Instruments [Table]
Debt Instrument [Line Items]
Debt instrument, repurchase amount
Principal At Issuance
Gross proceeds before issuance costs
Warrants at issued (common stock)
Preferred Shares
Maturity date
Maturity date
Number of shares to purchase capital stock
Warrants
Warrants exercise price
Principal amount
Warrants to purchase
Warrant exercise price per share
Class of warrant or right vesting term
Debt adjustment term
Debt instrument conversion rate
Debt instrument interest rate effective percent
Interest expense
Written notice period
Debt instrument, redemption price, percentage
Debt instrument, benchmark price per share
Conversion price, per share
Conversion price as a percentage of lowest stock price
Proceeds from issuance of sale of equity
Debt covenant, cumulative net sales requirement
Exercise price per share
Conversion price percentage
Proceeds from issuance of common stock
Debt instrument indebtedness amount
Debt instrument periodic payment
Cumulative net sales
Accrued interest percentage
Interest revenue expenses net
Interest amount
Convertible notes payable
Accumulated other comprehensive income
Principal and accrued interest
Debt instrument, debt default, description of notice of default
Coupon interest
Debt instrument convertible beneficial ownership limitation
Debt instrument weighted average price per share
Debt instrument weighted average period
Debt instrument convertible exchange percentage
Debt Conversion, Converted Instrument, Amount
Converted shares
Aggregate purchase price
Original principal and accrued interest amount
Series G1 shares deemed dividends
Restricted Cash
Convertible debt current principal amount
Convertible debt current accrued interest
Debt Instrument, Interest Rate, Stated Percentage
Interest rate increase
Redemption premium percentage
Share conversion price
Issuance of debt
Warrants purchase
Exercise price
Offering costs
Debt instrument, description
Short term debt
Annual interest rate
Raw materials
Work in process
Finished goods
Total
Insurance
Prescription Drug User Fee Act (PDUFA) fees
Receivable from Pharma 1
Outside service retainers
Short-term deposits
Other
Total
Property, Plant, and Equipment [Table]
Property, Plant, and Equipment [Line Items]
Property and equipment, gross
Useful Life
Less: accumulated depreciation
Total, net
Intellectual property
Intellectual property useful life
Less: accumulated amortization
Total, net
Accrued royalty
Accrued compensation for non-employee directors
Other
Total
Variable consideration related to net revenue
Liability for loss on purchase commitment
Deferred revenue
Other
Total
Amortization expense
Intangible asset fully amortized
Intangible assets expected remaining useful life
Intangible asset net
Fair Value, off-Balance-Sheet Risk [Table]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Principal Amount
Accrued Interest
Net Carrying Amount
Fair Value Amount
Interest paid in kind
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance
Payments
Change in fair value presented in the condensed consolidated statement of comprehensive operations
Change in fair value presented in the condensed consolidated statements of operations
Ending balance
Fair Value Measurement Inputs and Valuation Techniques [Table]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Interest rate
Risk free rate
Revenue volatility
Event probability
Earnout term
Net revenue
Lessee, Lease, Description [Table]
Lessee, Lease, Description [Line Items]
IncomeStatementsLocationAxis [Axis]
Operating lease expense
Weighted Average Remaining Lease Term (in years)
Weighted Average Discount Rate
Remainder of 2026 (9 months)
Year ending December 31, 2027
Total lease payments
Less imputed interest
Total
Operating cash outflows in operating leases
Loss Contingencies [Table]
Loss Contingencies [Line Items]
Total commitment amount
Purchases under commitment
Purchase Obligation, to be Paid, Year One
Purchase obligations
Royalty payments
Asset acquisition
Asset acquisition
Lessee, Operating Lease, Term of Contract
Leased vehicles
Merger agreement description
Aggregate original principal amount
Warrants to purchase
Bear interest rate
Issued discount amount
Principle amount
Proceeds from notes payable
Exercise price
Accounts payable, trade
Accrued expenses
Percentage of accounts payable trade
Contingency liability accrued
Description of debt notice of default
Debt default longterm debt description of notice
Accrued liabilities
Contingent liabilities
Accrued expenses
Royalty expense
Refund amount
Additional gain
Additional loss
Purchases
Accumulated Other Comprehensive Income (Loss) [Table]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Underlying common stock to be purchased
Warrants exercise period
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock reserved upon exercise of stock options outstanding
Common stock reserved upon exercise of common stock warrants
Common Stock available for future issuance under the 2025 Plan
Common stock reserved for the exercise of purchase rights
Common stock reserved for the conversion of convertible notes
Common stock reserved for the conversion of series E-1 preferred stock
Common stock reserved for the conversion of series E-1 preferred stock
Total common stock reserved for future issuance
Class of Warrant or Right [Table]
Class of Warrant or Right [Line Items]
Warrants to purchase common stock
Warrants term
Common stock warrant outstanding
Beneficial ownership limitation percentage
Exercise price
Conversion price
Percentage of conversion amount.
Dividend rate description
Redemption premium percentage
Debt Conversion, Original Debt, Amount
Debt Conversion, Converted Instrument, Shares Issued
Shares issued
Common Stock shares
Common Stock upon conversion shares
Shares issued for purchase rights
Number of shares issued
Share purchase price
Proceeds from merger
Cash received recorded as additional paid-in-capital
Debt Instrument, Repaid, Principal
Volume weighted average price description
Dividends common stock paid-in-kind, percentage
Shares issued for purchase rights
Purchase rights
[custom:IncreaseDecreaseInPurchaseRightsOutstanding]
[custom:PurchaseRightsOutstanding-0]
DisclosureOfCompensationRelatedCostsSharebasedPaymentsTable [Table]
Total
Equity awards issued
Stock-based compensation awards issued
Unrecognized stock-based compensation expense
Adjuvant Notes [Member]
Baker Bros Notes [Member]
Contingent liabilities current.
Contingent liabilities noncurrent.
Series E-1 Convertible and Redeemable Preferred Stock [Member]
Series F-1 Convertible and Redeemable Preferred Stock [Member]
Series G-1 Convertible and Redeemable Preferred Stock [Member]
Research and development, net.
Change in fair value of financial instruments.
Convertible preferred deemed dividends series E1 and G1 shares dividends.
Convertible preferred deemed dividends series E1 and G1 shares dividends shares.
Inventory writedown for excess obsolescence.
Loss on contingent liability.
Gain loss on accounts payable settlements.
Increase decrease in contingent liabilities.
Net increase/(decrease) in contingent consideration liabilities.
Purchases of property and equipment included in accounts payable and accrued expenses.
Series E-1 and G-1 Shares deemed dividends.
Issuance of common stock upon conversion of notes.
Working capital surplus deficit.
Accumulated deficit.
Three Largest Customers Combined [Member]
Purchase rights change in fair value.
Weighted average shares used to compute net loss attributable to common stockholder basic.
Contract with customer payment term.
Product revenue variable consideration liability current.
Baker Second Closing Notes [Member]
Class of warrant or right vesting term
Debt instrument, convertible, written notice period.
Debt instrument, convertible, conversion price, percentage of lowest stock price.
Milestone method revenues recognized.
Second Baker Amendment [Member]
Baker Warrants [Member]
Third Baker Amendment [Member]
Secured Creditor Forbearance Agreement [Member]
Cumulative net sales.
Accrued interest agreement percentage.
= $5.0 million [Member]
>$5.0 million and = $7.0 million [Member]
Quarterly Cash Payment [Member]
Greater than $7.0 million [Member]
Quarterly Cash Payment [Member]
On Or Prior To September 8, 2024 [Member]
Baker Notes [Member]
September 9, 2024 - September 8, 2025 [Member]
September 9, 2025 - September 8, 2026 [Member]
September 9, 2026 - September 8, 2027 [Member]
September 9, 2027 - September 8, 2028 [Member]
Principal and accrued interest.
Short-term Convertible Notes [Member]
Debt instrument convertible beneficial ownership limitation.
Debt instrument convertible weighted average price per share.
Debt instrument convertible weighted average period.
Debt instrument convertible exchange percentage.
Common Stock Agreements [Member]
Original principal and accrued interest amount.
Series G-1 shares deemed dividends.
Convertible debt current principal amount.
Convertible debt current accrued interest.
A80 Senior Subordinated Notes Due 2025 Issued December2022 [Member]
Securities Purchase Agreements [Member]
Debt instrument interest rate in event of default.
Debt instrument redemption premium in event of default.
Series F-1 Convertible Preferred Stock [Member]
Security Purchase Agreement [Member]
Aditxt Note [Member]
Schedule Of Senior Subordinated Notes And Warrants [Table Text Block]
December 2022 Notes [Member]
February 2023 Notes [Member]
March 2023 Notes [Member]
March Two 2023 Notes [Member]
April 2023 Notes [Member]
July 2023 Notes [Member]
August 2023 Notes [Member]
September 2023 Notes [Member]
Aditxt April Notes [Member]
Aditxt June Notes [Member]
Debt instrument current maturity date.
Placement Agent [Member]
December 2022 to September 2023 and April to June 2025 [Member]
Common Warrant [Member]
Pre-Funded Warrants [Member]
Insurance Premium Finance Agreement [Member]
Short term financed borrowings.
NonRule10B51ArrModifiedFlag
Rule10B51ArrModifiedFlag
Statement of financial positions location balance axis.
PDUFA fees.
Prepaid receivable current.
Prepaid, outside service retainers.
Computer Equipment and Software [Member]
Variable considerations related to revenue current.
Liability for loss on purchase commitment
Aditxt Notes [Member]
Baker Notes Assigned To FuturePak [Member]
Total Offerings and Aditxt Notes [Member]
Series G-1 Shares [Member]
Series F-1 Shares [Member]
Series E-1 Shares [Member]
Accounting policies for correction of previously issued interim financial statements and prior period errors.
June 2022 Baker Warrants [Member]
Tabular disclosure of cash payments determined based upon the quarterly global net revenue.
Others Current Liabilities [Member]
Long term purchase commitment expected amount
Lease Contract Term One [Member]
Lease Contract Term [Member]
Number of leased vehicles.
Measurement Input Royalty Rate [Member]
Fair value assumption rate.
Risk Free Interest Rate [Member]
Income Approach [Member]
Discount Rate [Member]
Weighted Average Cost of Capital [Member]
Assumption volatility rate.
Volatility [Member]
Schedule of Lease Term and Discount Rate [Table Text Block]
Probability weighted discounted cash flows assumption rate.
Event Probability [Member]
Exchanged Ssn and Aditxt Notes [Member]
Equity Volatility [Member]
Discount for Lack of Marketability [Member]
Earnout term.
Net revenues.
Merger agreement description of acquired entity.
Principle amount.
Accounts payable trade 90 days past due or more percent.
Future Pak LLC [Member]
Debt default longterm debt description of notice.
Rush License Agreement [Member]
Contingent liabilities.
Refund amount
Additional gain.
Additional loss.
Income statements location axis.
Research and Development Expenses [Member]
Selling and Marketing Expenses [Member]
General and Administrative Expenses [Member]
Baker Bros Purchase Agreement [Member]
Underwritten Public Offering [Member]
June 2022 Baker Warrants [Member]
Warrant One [Member]
Warrant Two [Member]
Warrant Three [Member]
Common Warrants [Member]
Prefunded Common Warrants [Member]
Warrants exercise period, description.
Series E-1 Convertible Preferred Stock [Member]
Preferred stock redemption premium percentage.
A&R Merger Agreement [Member]
Series G-1 Convertible Preferred Stock [Member]
Volume weighted average price description.
Dividends common stock paid-in-kind, percentage.
Adjuvant and May 2022 Notes [Member]
Purchase rights.
Increase decrease in purchase rights outstanding.
Purchase rights outstanding.
Common stock reserved upon exercise of stock options outstanding.
Common stock reserved up on exercise of common stock warrants.
Employee Stock Purchase Plan 2019 [Member]
Amended Inducement Plan [Member]
2025 Plan [Member]
Common stock reserved for the exercise of purchase rights.
Preferred stock capital shares reserved for future issuance one.
Statement of Income Locations Balance [Axis]
Research and Development [Member]
Selling and Marketing [Member]
General and Administrative [Member]
Quarterly Cash Payment [Member] [Default Label]
June 2022 Baker Warrants [Member] [Default Label]
Assets, Current
Assets [Default Label]
Liabilities, Current
Liabilities
Equity, Attributable to Parent
Liabilities and Equity
Costs and Expenses
Operating Income (Loss)
Other Nonoperating Expense
Nonoperating Income (Expense)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Income Tax Expense (Benefit)
Preferred Stock Dividends, Income Statement Impact
Shares, Outstanding
Share-Based Payment Arrangement, Noncash Expense
Gain (Loss) on Disposition of Property Plant Equipment
GainLossOnAccountsPayableSettlements
Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Inventories
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Accounts Payable
Increase (Decrease) in Employee Related Liabilities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Payments to Acquire Intangible Assets
Payments to Acquire Property, Plant, and Equipment
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Repayments of Short-Term Debt
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
RetainedEarningsAccumulatedDeficits
Net Income (Loss) Available to Common Stockholders, Diluted
DebtInstrumentCurrentMaturityDate
Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization
Intangible Asset, Finite-Lived, Accumulated Amortization
Other Accrued Liabilities, Current
Other Sundry Liabilities, Current
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases
Lessee, Operating Lease, Liability, to be Paid
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Operating Lease, Liability
Asset Acquisition, Contingent Consideration, Liability, Noncurrent
ContingentLiabilities
Accounts Payable and Accrued Liabilities, Current
PreferredStockCapitalSharesReservedForFutureIssuanceOne
PreferredStockRedemptionPremiumPercentage
Stock Issued During Period, Shares, Purchase of Assets
Share-Based Payment Arrangement, Expense